These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 33174044

  • 1. Narasin inhibits tumor metastasis and growth of ERα‑positive breast cancer cells by inactivation of the TGF‑β/SMAD3 and IL‑6/STAT3 signaling pathways.
    Chen J, Huang X, Li N, Liu B, Ma Z, Ling J, Yang W, Li T.
    Mol Med Rep; 2020 Dec; 22(6):5113-5124. PubMed ID: 33174044
    [Abstract] [Full Text] [Related]

  • 2. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
    Chen J, Li N, Liu B, Ling J, Yang W, Pang X, Li T.
    Life Sci; 2020 May 01; 248():117469. PubMed ID: 32109485
    [Abstract] [Full Text] [Related]

  • 3. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L, Liu LJ, Yan YM, Fu R, Li Y, Xu Y, Cheng YX, Wu ZQ.
    J Exp Clin Cancer Res; 2019 Mar 21; 38(1):134. PubMed ID: 30898152
    [Abstract] [Full Text] [Related]

  • 4. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J, Alvarado-Muñoz JF, Escobar-Arriaga E, Ulloa-Aguirre A, de Jesús Ibarra-Sánchez M.
    BMC Cancer; 2019 Jul 23; 19(1):728. PubMed ID: 31337349
    [Abstract] [Full Text] [Related]

  • 5. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.
    Carcinogenesis; 2013 Apr 23; 34(4):874-84. PubMed ID: 23275155
    [Abstract] [Full Text] [Related]

  • 6. Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in cellular and xenografted breast cancer models.
    Go RE, Kim CW, Jeon SY, Byun YS, Jeung EB, Nam KH, Choi KC.
    Environ Toxicol; 2017 Apr 23; 32(4):1439-1454. PubMed ID: 27539251
    [Abstract] [Full Text] [Related]

  • 7. IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis.
    Siersbæk R, Scabia V, Nagarajan S, Chernukhin I, Papachristou EK, Broome R, Johnston SJ, Joosten SEP, Green AR, Kumar S, Jones J, Omarjee S, Alvarez-Fernandez R, Glont S, Aitken SJ, Kishore K, Cheeseman D, Rakha EA, D'Santos C, Zwart W, Russell A, Brisken C, Carroll JS.
    Cancer Cell; 2020 Sep 14; 38(3):412-423.e9. PubMed ID: 32679107
    [Abstract] [Full Text] [Related]

  • 8. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu Z, Zhao J, Zhang HT.
    Int J Oncol; 2014 May 14; 44(5):1643-51. PubMed ID: 24573038
    [Abstract] [Full Text] [Related]

  • 9. Natural Diterpenoid Isoferritin A (IsoA) Inhibits Glioma Cell Growth and Metastasis via Regulating of TGFβ-Induced EMT Signal Pathway.
    Shen B, Sun D.
    Med Sci Monit; 2018 Jun 06; 24():3815-3823. PubMed ID: 29873321
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer.
    Wang S, Huang M, Wang Z, Wang W, Zhang Z, Qu S, Liu C.
    Int J Oncol; 2019 Nov 06; 55(5):1097-1109. PubMed ID: 31545407
    [Abstract] [Full Text] [Related]

  • 11. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS, Lee WS, Jeong J, Kim SJ, Jin W.
    Oncotarget; 2015 Nov 24; 6(37):40158-71. PubMed ID: 26515594
    [Abstract] [Full Text] [Related]

  • 12. Brusatol inhibits laryngeal cancer cell proliferation and metastasis via abrogating JAK2/STAT3 signaling mediated epithelial-mesenchymal transition.
    Zhou J, Hou J, Wang J, Wang J, Gao J, Bai Y.
    Life Sci; 2021 Nov 01; 284():119907. PubMed ID: 34453950
    [Abstract] [Full Text] [Related]

  • 13. Bakuchiol, main component of root bark of Ulmus davidiana var. japonica, inhibits TGF-β-induced in vitro EMT and in vivo metastasis.
    Lee DE, Jang EH, Bang C, Kim GL, Yoon SY, Lee DH, Koo J, Na JH, Lee S, Kim JH.
    Arch Biochem Biophys; 2021 Sep 30; 709():108969. PubMed ID: 34153297
    [Abstract] [Full Text] [Related]

  • 14. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
    Wang L, Zhan X, Shen X, Li M, Yang J, Yu W, Chen H, Jin B, Mao Z.
    Mol Cell Biochem; 2018 Sep 30; 446(1-2):137-148. PubMed ID: 29388151
    [Abstract] [Full Text] [Related]

  • 15. Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.
    Cherlet T, Murphy LC.
    Mol Cell Biochem; 2007 Dec 30; 306(1-2):33-42. PubMed ID: 17660955
    [Abstract] [Full Text] [Related]

  • 16. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
    Kim YS, Choi KC, Hwang KA.
    Phytomedicine; 2015 Oct 15; 22(11):993-9. PubMed ID: 26407941
    [Abstract] [Full Text] [Related]

  • 17. Human adipose‑derived mesenchymal stem cells promote breast cancer MCF7 cell epithelial‑mesenchymal transition by cross interacting with the TGF‑β/Smad and PI3K/AKT signaling pathways.
    Wu S, Wang Y, Yuan Z, Wang S, Du H, Liu X, Wang Q, Zhu X.
    Mol Med Rep; 2019 Jan 15; 19(1):177-186. PubMed ID: 30483746
    [Abstract] [Full Text] [Related]

  • 18. A novel anthraquinone‑quinazoline hybrid 7B blocks breast cancer metastasis and EMT via targeting EGFR and Rac1.
    Kang J, Zhong Y, Tian W, Li J, Li X, Zhai L, Hou H, Li D.
    Int J Oncol; 2021 May 15; 58(5):. PubMed ID: 33760108
    [Abstract] [Full Text] [Related]

  • 19. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
    Wang J, Xu J, Xing G.
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep 01; 49(9):771-779. PubMed ID: 28910973
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.